ALLMedicine™ Brugada Syndrome Center

Nov 23rd, 2020 - Background Sinus tachycardia during exercise attenuates ST-segment elevation in patients with Brugada syndrome, whereas ST-segment augmentation after an exercise test is a high-risk sign. Some patients have premature ventricular contractions (PVCs...

Nov 22nd, 2020 - Brugada syndrome (BrS) is associated with an increased risk of sudden cardiac death due to ventricular tachycardia/fibrillation (VT/VF) in young, otherwise healthy individuals. Despite SCN5A being the most commonly known mutated gene to date, the ...

Nov 20th, 2020 - Alterations in the SCN5A gene encoding the cardiac sodium channel Nav1.5 have been linked to a number of arrhythmia syndromes and diseases including long-QT syndrome (LQTS), Brugada syndrome (BrS) and dilative cardiomyopathy (DCM), which may predi...

Nov 16th, 2020 - We assessed the relationship between day-to-day variation of the early repolarization (ER) pattern and ventricular tachyarrhythmia (VTA) events in Brugada syndrome (BrS) patients because the clinical implications are unclear.Methods and Results:Th...

Nov 13th, 2020 - Brugada syndrome is an arrhythmogenic disease with often fatal outcome in otherwise healthy and young individuals. Anamnesis and ECG are cornerstones in a syncope workup. In our case, a 27-year-old male presented to the emergency department due to...

Jul 31st, 2018 - Our analysis has 2 objectives. First, to evaluate whether ventricular arrhythmias (VAs) induced with programmed electrostimulation in asymptomatic patients with Brugada syndrome identify a higher risk group that may require additional testing or t.

Nov 23rd, 2020 - Background Sinus tachycardia during exercise attenuates ST-segment elevation in patients with Brugada syndrome, whereas ST-segment augmentation after an exercise test is a high-risk sign. Some patients have premature ventricular contractions (PVCs...

Nov 22nd, 2020 - Brugada syndrome (BrS) is associated with an increased risk of sudden cardiac death due to ventricular tachycardia/fibrillation (VT/VF) in young, otherwise healthy individuals. Despite SCN5A being the most commonly known mutated gene to date, the ...

Nov 20th, 2020 - Alterations in the SCN5A gene encoding the cardiac sodium channel Nav1.5 have been linked to a number of arrhythmia syndromes and diseases including long-QT syndrome (LQTS), Brugada syndrome (BrS) and dilative cardiomyopathy (DCM), which may predi...

Nov 16th, 2020 - We assessed the relationship between day-to-day variation of the early repolarization (ER) pattern and ventricular tachyarrhythmia (VTA) events in Brugada syndrome (BrS) patients because the clinical implications are unclear.Methods and Results:Th...

Nov 13th, 2020 - Brugada syndrome is an arrhythmogenic disease with often fatal outcome in otherwise healthy and young individuals. Anamnesis and ECG are cornerstones in a syncope workup. In our case, a 27-year-old male presented to the emergency department due to...

Nov 3rd, 2020 - NEW YORK (Reuters Health) - A new risk stratification model for patients with Brugada syndrome (BrS) is based on four risk factors for ventricular arrhythmias/sudden cardiac death (VA/SCD) and can inform the need for an implantable cardioverter de...

Nov 3rd, 2020 - NEW YORK (Reuters Health) - A new risk stratification model for patients with Brugada syndrome (BrS) is based on four risk factors for ventricular arrhythmias/sudden cardiac death (VA/SCD) and can inform the need for an implantable cardioverter de...

Jul 8th, 2018 - A study reevaluating genes reported to be associated with Brugada syndrome challenged the validity of all but one. (Circulation) The American College of Cardiology renamed its ACTION Registry under the National Cardiovascular Data Registry umbrell...

Oct 10th, 2017 - Action Points Long-term follow-up of Brugada syndrome patients confirmed the efficacy of implanted cardioverter-defibrillator (ICD) devices but also substantial adverse event risk. The predictors of appropriate therapy were a type 1 electrocardiog...

Sep 11th, 2017 - The Absorb bioresorbable stent will come rapidly off the market worldwide due to poor sales, Abbott announced, although the firm may return with a second-generation device. MedPage Today has the full story here. Kids' exposure to chemical-laden du...